Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ·Healthcare·Biotechnology
$5.51
+4.95%
Mkt Cap $53.91M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$17.00
Range $17.00 – $17.00
Implied Upside
+208.5%
Consensus $17.00 vs current $5.51
NASDAQ·Healthcare·Biotechnology
$5.51
+4.95%
Mkt Cap $53.91M
No recent rating data.
Price Target (4 analysts)
$17.00
Range $17.00 – $17.00
+208.5%
Consensus $17.00 vs current $5.51